Comparison of linear accelerator and helical tomotherapy plans for glioblastoma multiforme patients.

BACKGROUND Despite advances in radiotherapy, overall survival of glioblastoma multiforme (GBM) patients is still poor. Moreover dosimetrical analyses with these newer treatment methods are insufficient. The current study is aimed to compare intensity modulated radiation therapy (IMRT) linear accelerator (linac) and helical tomotherapy (HT) treatment plans for patients with prognostic aggressive brain tumors. MATERIAL AND METHODS A total of 20 GBM patient plans were prospectively evaluated in both linac and HT planning systems. Plans are compared with respect to homogenity index, conformity index and organs at risk (OAR) sparing effects of the treatments. RESULTS Both treatment plans provided good results that can be applied to GBM patients but it was concluded that if the critical organs with relatively lower dose constraints are closer to the target region, HT for radiotherapeutical application could be preferred. CONCLUSION Tomotherapy plans were superior to linear accelerator plans from the aspect of OAR sparing with slightly broader low dose ranges over the healthy tissues. In case a clinic has both of these IMRT systems, employment of HT is recommended based on the observed results and future re-irradiation strategies must be considered.

[1]  Z. Master,et al.  Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation. , 2012, International journal of radiation oncology, biology, physics.

[2]  Daliang Cao,et al.  Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. , 2007, International journal of radiation oncology, biology, physics.

[3]  M. Mackenzie,et al.  Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. , 2008, International journal of radiation oncology, biology, physics.

[4]  J. Shao,et al.  AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[5]  T. Kehwar,et al.  Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model. , 2005, Journal of cancer research and therapeutics.

[6]  M. Oldham,et al.  Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. , 1999, International journal of radiation oncology, biology, physics.

[7]  T. Jiang,et al.  Effect of intensity‐modulated radiotherapy versus three‐dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme , 2013, Chinese medical journal.

[8]  R Mohan,et al.  A method for determining multileaf collimator transmission and scatter for dynamic intensity modulated radiotherapy. , 2000, Medical physics.

[9]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[10]  Maria T. Vlachaki,et al.  Intensity modulated radiation therapy versus three‐dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison , 2007, Journal of applied clinical medical physics.

[11]  Chengyu Shi,et al.  Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures , 2007, Physics in medicine and biology.

[12]  Ke Sheng,et al.  A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme , 2007, Radiation oncology.

[14]  N. Papanikolaou,et al.  Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index. , 2008, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[15]  K. Camphausen,et al.  A dosimetric comparison of four treatment planning methods for high grade glioma , 2009, Radiation oncology.

[16]  P. Giraud,et al.  Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study. , 2014, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[17]  Hongyang Zhao,et al.  DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[18]  P. C. Williams.  IMRT: delivery techniques and quality assurance. , 2003, The British journal of radiology.

[19]  Wei-Guo Zhu,et al.  Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[20]  C. Thilmann,et al.  Intensity‐modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high‐grade gliomas , 2001, International journal of cancer.

[21]  A. Okumura,et al.  Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases , 2008, Journal of Neuro-Oncology.

[22]  M. Doroudchi,et al.  Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[23]  U. Hermanto,et al.  Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? , 2007, International journal of radiation oncology, biology, physics.

[24]  N. Saito,et al.  Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma. , 2012, Neurologia medico-chirurgica.

[25]  E. B. Butler,et al.  Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. , 2004, International journal of radiation oncology, biology, physics.

[26]  K. Hogstrom,et al.  Preliminary comp arison of helical tomotherapy and mixed beams of unmodulated electrons and intensity modulated radiation therapy for treating superficial cancers of the parotid gland and nasal cavity , 2011, Radiation oncology.

[27]  M. Kong,et al.  Clinical outcome of helical tomotherapy for inoperable non- small cell lung cancer: the Kyung Hee University Medical Center experience. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[28]  A. Taghian,et al.  Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. , 1988, International journal of radiation oncology, biology, physics.

[29]  V. Grégoire,et al.  A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Z. Master,et al.  Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT. , 2010, Journal of cancer research and therapeutics.

[31]  A. Safaei,et al.  Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[32]  Patient Specification Quality Assurance for Glioblastoma Multiforme Brain Tumors Treated with Intensity Modulated Radiation Therapy , 2011, International journal of medical sciences.

[33]  Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. , 2004, International journal of radiation oncology, biology, physics.